Vinva Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$633K Buy
+7,235
New +$303K ﹤0.01% 386
2025
Q4
– Sell
-4,015
Closed -$205K – 472
2025
Q3
$205K Sell
4,015
-6,900
-63% -$198K ﹤0.01% 419
2025
Q2
$458K Buy
+10,915
New +$316K 0.01% 359
2025
Q1
– Sell
-8,929
Closed -$575K – 437
2024
Q4
$575K Sell
8,929
-6,337
-42% -$240K 0.02% 340
2024
Q3
$744K Buy
+15,266
New +$429K 0.03% 335

Other funds holding VCYT

Vinva Investment Management's VCYT Position: Q2 2026 in Review

Vinva Investment Management opened a new position in Veracyte (VCYT) in Q2 2026: 7,235 shares worth $633K. The stake represents ﹤0.01% of the portfolio and ranks #386 among its holdings. This is a return to the name: Vinva Investment Management previously reported a position in VCYT as recently as Q3 2025.

Vinva Investment Management first reported a position in VCYT in Q3 2024 and has held it in 5 quarters since. The position peaked at $744K in Q3 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Vinva Investment Management held 7,235 shares of Veracyte worth $633K as of Q2 2026.
  • Veracyte was a new Vinva Investment Management position in Q2 2026.
  • Veracyte made up ﹤0.01% of Vinva Investment Management's portfolio in Q2 2026, its #386 holding.
  • Vinva Investment Management first reported a position in Veracyte in Q3 2024 and has held it in 5 quarters since.
  • Vinva Investment Management's Veracyte position peaked at $744K in Q3 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.